Andrieux et al., 2004 - Google Patents
Insertion and partition of sodium taurocholate into egg phosphatidylcholine vesiclesAndrieux et al., 2004
- Document ID
- 18135478394410432298
- Author
- Andrieux K
- Forte L
- Lesieur S
- Paternostre M
- Ollivon M
- Grabielle-Madelmont C
- Publication year
- Publication venue
- Pharmaceutical research
External Links
Snippet
Purpose. To get a continuous description of the insertion and partition processes of sodium taurocholate (TC) into the lipid bilayers of vesicles that can serve as a model for understanding the mechanism of destabilization by the bile salts of liposomes used as drug …
- 238000003780 insertion 0 title abstract description 33
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Daear et al. | Applications of Brewster angle microscopy from biological materials to biological systems | |
Weder et al. | The preparation of variably sized homogeneous liposomes for laboratory, clinical, and industrial use by controlled detergent dialysis | |
Anwekar et al. | Liposome-as drug carriers. | |
US5882679A (en) | Liposomes containing active agents aggregated with lipid surfactants | |
US4917951A (en) | Lipid vesicles formed of surfactants and steroids | |
Weiner et al. | Liposomes as a drug delivery system | |
Wang et al. | Preparation of submicron unilamellar liposomes by freeze-drying double emulsions | |
US5043164A (en) | Blood-stable, cholesterol-free liposomes | |
Cevc et al. | Lipid vesicles and membrane fusion | |
Touitou et al. | Liposomes as carriers for topical and transdermal delivery | |
Schubert | Liposome preparation by detergent removal | |
Papahadjopoulos et al. | Studies on membrane fusion. 1. Interactions of pure phospholipid membranes and the effect of myristic acid, lysolecithin, proteins and dimethylsulfoxide | |
KR0137783B1 (en) | Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated | |
Zumbuehl et al. | Liposomes of controllable size in the range of 40 to 180 nm by defined dialysis of lipid/detergent mixed micelles | |
Xia et al. | Mechanistic studies on surfactant-induced membrane permeability enhancement | |
Sahin | Niosomes as nanocarrier systems | |
JP2521377B2 (en) | Penetration dependent vesicles | |
EP0349579B1 (en) | Lipid vesicles formed of surfactants and steroids | |
JPH06501246A (en) | Accumulation of amino acids and peptides within liposomes | |
Angelini et al. | Characterization of cationic liposomes. Influence of the bilayer composition on the kinetics of the liposome breakdown | |
Andrieux et al. | Insertion and partition of sodium taurocholate into egg phosphatidylcholine vesicles | |
Afdhal et al. | Mucin-vesicle interactions in model bile: evidence for vesicle aggregation and fusion before cholesterol crystal formation | |
Hincha | Effects of calcium-induced aggregation on the physical stability of liposomes containing plant glycolipids | |
US6399094B1 (en) | Unilamellar liposomal preparations with high active substance content | |
Tasi et al. | Microcalorimetric investigation of the interaction of polysorbate surfactants with unilamellar phosphatidylcholines liposomes |